Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASH 2015 | From epigenetic mechanisms to cancer therapeutics

Stephen Nimer • 4 Dec 2015
ASH 2015
General

At the 58th American Society of Hematology (ASH) Annual Meeting & Exposition, Stephen Nimer, MD, from Memorial Sloan-Kettering Cancer Center, New York, NY, reviews promising epigenetic targets in cancer and explains that combining epigenetic therapies with immunotherapies may improve outcomes for patients.

More from Stephen Nimer

Future potential of stem-cell-directed therapies in the treatment landscape for AML
1:00
Future potential of stem-cell-directed therapies in the treatment landscape for AML
Stephen Nimer • 7 Oct 2026
Exploring CARM1 as a leukemia-specific stem cell vulnerability whilst retaining normal hematopoiesis
1:23
Exploring CARM1 as a leukemia-specific stem cell vulnerability whilst retaining normal hematopoiesis
Stephen Nimer • 18 Sep 2026
Disrupting leukemia stem-cell self-renewal versus differentiation therapy in AML
1:33
Disrupting leukemia stem-cell self-renewal versus differentiation therapy in AML
Stephen Nimer • 18 Sep 2026
Insights into the potential of therapeutically targeting leukemic stem cell properties in AML
1:52
Insights into the potential of therapeutically targeting leukemic stem cell properties in AML
Stephen Nimer • 18 Sep 2026

Related Videos

The ethical challenges of AI in hematology: patient communication, trust and regulation
3:12
The ethical challenges of AI in hematology: patient communication, trust and regulation
Adrián Mosquera Orgueira • 24 Sep 2026
The future of AI in hematology: personalized medicine, opportunities and risks
2:30
The future of AI in hematology: personalized medicine, opportunities and risks
Adrián Mosquera Orgueira • 24 Sep 2026
The multi-system impacts of CHIP and its link to subspecialties within internal medicine
5:18
The multi-system impacts of CHIP and its link to subspecialties within internal medicine
Shyam Patel • 13 Oct 2026
The scientific and clinical implications of therapy-related CHIP in oncology
2:43
The scientific and clinical implications of therapy-related CHIP in oncology
Shyam Patel • 13 Oct 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals